Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine

Identifieur interne : 001085 ( Main/Exploration ); précédent : 001084; suivant : 001086

Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine

Auteurs : YING JU [République populaire de Chine] ; HONGXIA FAN [République populaire de Chine] ; JUN LIU [République populaire de Chine] ; JUN HU [République populaire de Chine] ; XINGHUI LI [République populaire de Chine] ; CHANGFEI LI [République populaire de Chine] ; LIZHAO CHEN [République populaire de Chine] ; QIANG GAO [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; SONGDONG MENG [République populaire de Chine]

Source :

RBID : Pascal:14-0126704

Descripteurs français

English descriptors

Abstract

The commonly used inactivated or split influenza vaccines induce only induce minimal T cell responses and are less effective in preventing heterologous virus infection. Thus, developing cross-protective influenza vaccines against the spread of a new influenza virus is an important strategy against pandemic emergence. Here we demonstrated that immunization with heat shock protein gp96 as adjuvant led to a dramatic increased antigen-specific T cell response to a pandemic H1N1 split vaccine. Notably, gp96 elicited a cross-protective CD8+ T cell response to the internal conserved viral protein NP. Although the split pH1N1vaccine alone has low cross-protective efficiency, adding gp96 as an adjuvant effectively improved the cross-protection against challenge with a heterologous virus in mice. Our study reveals the novel property of gp96 in boosting the T cell response against conserved epitopes of influenza virus and its potential use as an adjuvant for human pre-pandemic inactivated influenza vaccines against different viral subtypes.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine</title>
<author>
<name sortKey="Ying Ju" sort="Ying Ju" uniqKey="Ying Ju" last="Ying Ju">YING JU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hongxia Fan" sort="Hongxia Fan" uniqKey="Hongxia Fan" last="Hongxia Fan">HONGXIA FAN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jun Liu" sort="Jun Liu" uniqKey="Jun Liu" last="Jun Liu">JUN LIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jun Hu" sort="Jun Hu" uniqKey="Jun Hu" last="Jun Hu">JUN HU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xinghui Li" sort="Xinghui Li" uniqKey="Xinghui Li" last="Xinghui Li">XINGHUI LI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Changfei Li" sort="Changfei Li" uniqKey="Changfei Li" last="Changfei Li">CHANGFEI LI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lizhao Chen" sort="Lizhao Chen" uniqKey="Lizhao Chen" last="Lizhao Chen">LIZHAO CHEN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qiang Gao" sort="Qiang Gao" uniqKey="Qiang Gao" last="Qiang Gao">QIANG GAO</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Sinovac Biotech Co., Ltd</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gao, George F" sort="Gao, George F" uniqKey="Gao G" first="George F." last="Gao">George F. Gao</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Songdong Meng" sort="Songdong Meng" uniqKey="Songdong Meng" last="Songdong Meng">SONGDONG MENG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">14-0126704</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0126704 INIST</idno>
<idno type="RBID">Pascal:14-0126704</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000108</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001D11</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000094</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000094</idno>
<idno type="wicri:doubleKey">0264-410X:2014:Ying Ju:heat:shock:protein</idno>
<idno type="wicri:Area/Main/Merge">001095</idno>
<idno type="wicri:Area/Main/Curation">001085</idno>
<idno type="wicri:Area/Main/Exploration">001085</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine</title>
<author>
<name sortKey="Ying Ju" sort="Ying Ju" uniqKey="Ying Ju" last="Ying Ju">YING JU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hongxia Fan" sort="Hongxia Fan" uniqKey="Hongxia Fan" last="Hongxia Fan">HONGXIA FAN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jun Liu" sort="Jun Liu" uniqKey="Jun Liu" last="Jun Liu">JUN LIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jun Hu" sort="Jun Hu" uniqKey="Jun Hu" last="Jun Hu">JUN HU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xinghui Li" sort="Xinghui Li" uniqKey="Xinghui Li" last="Xinghui Li">XINGHUI LI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Changfei Li" sort="Changfei Li" uniqKey="Changfei Li" last="Changfei Li">CHANGFEI LI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lizhao Chen" sort="Lizhao Chen" uniqKey="Lizhao Chen" last="Lizhao Chen">LIZHAO CHEN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qiang Gao" sort="Qiang Gao" uniqKey="Qiang Gao" last="Qiang Gao">QIANG GAO</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Sinovac Biotech Co., Ltd</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gao, George F" sort="Gao, George F" uniqKey="Gao G" first="George F." last="Gao">George F. Gao</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Songdong Meng" sort="Songdong Meng" uniqKey="Songdong Meng" last="Songdong Meng">SONGDONG MENG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), No. 1 West Beichen Road</s1>
<s2>Chaoyang District, Beijing 100101</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antigenic determinant</term>
<term>Cellular immunity</term>
<term>Cross protection</term>
<term>Heat shock protein</term>
<term>Immunological adjuvant</term>
<term>Influenza A</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Protéine choc thermique</term>
<term>Adjuvant immunologique</term>
<term>Immunité cellulaire</term>
<term>Protection croisée</term>
<term>Vaccin</term>
<term>Déterminant antigénique</term>
<term>Grippe A</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Vaccin</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The commonly used inactivated or split influenza vaccines induce only induce minimal T cell responses and are less effective in preventing heterologous virus infection. Thus, developing cross-protective influenza vaccines against the spread of a new influenza virus is an important strategy against pandemic emergence. Here we demonstrated that immunization with heat shock protein gp96 as adjuvant led to a dramatic increased antigen-specific T cell response to a pandemic H1N1 split vaccine. Notably, gp96 elicited a cross-protective CD8
<sup>+</sup>
T cell response to the internal conserved viral protein NP. Although the split pH1N1vaccine alone has low cross-protective efficiency, adding gp96 as an adjuvant effectively improved the cross-protection against challenge with a heterologous virus in mice. Our study reveals the novel property of gp96 in boosting the T cell response against conserved epitopes of influenza virus and its potential use as an adjuvant for human pre-pandemic inactivated influenza vaccines against different viral subtypes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Pékin</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Ying Ju" sort="Ying Ju" uniqKey="Ying Ju" last="Ying Ju">YING JU</name>
</noRegion>
<name sortKey="Changfei Li" sort="Changfei Li" uniqKey="Changfei Li" last="Changfei Li">CHANGFEI LI</name>
<name sortKey="Gao, George F" sort="Gao, George F" uniqKey="Gao G" first="George F." last="Gao">George F. Gao</name>
<name sortKey="Hongxia Fan" sort="Hongxia Fan" uniqKey="Hongxia Fan" last="Hongxia Fan">HONGXIA FAN</name>
<name sortKey="Jun Hu" sort="Jun Hu" uniqKey="Jun Hu" last="Jun Hu">JUN HU</name>
<name sortKey="Jun Liu" sort="Jun Liu" uniqKey="Jun Liu" last="Jun Liu">JUN LIU</name>
<name sortKey="Lizhao Chen" sort="Lizhao Chen" uniqKey="Lizhao Chen" last="Lizhao Chen">LIZHAO CHEN</name>
<name sortKey="Qiang Gao" sort="Qiang Gao" uniqKey="Qiang Gao" last="Qiang Gao">QIANG GAO</name>
<name sortKey="Songdong Meng" sort="Songdong Meng" uniqKey="Songdong Meng" last="Songdong Meng">SONGDONG MENG</name>
<name sortKey="Xinghui Li" sort="Xinghui Li" uniqKey="Xinghui Li" last="Xinghui Li">XINGHUI LI</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001085 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001085 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:14-0126704
   |texte=   Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021